Deep dive into
Imeka lets you see white matter like you’ve never seen it before.
Come see how our imaging technology takes your research further.
Tracking and quantifying measures that matter
Imeka’s ANIE biomarker platform identifies inflammation, demyelination, and axonal degeneration and is robust to crossing fibers.
We specialize in neurodegenerative diseases
Rely on our expertise in Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and other white matter pathologies.
Optimize and streamline your pipeline
Learn if, how, and where in the brain your potential therapeutics are working.
Studied and proven, with over 10 years of experience.
Imeka’s technology has benefited experts from pharmaceutical companies to researchers.
Like you, our main goal is to play an influential role—and minimize risk—in the search for and development of cures for brain diseases.